HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SINEUP Non-coding RNA Targeting GDNF Rescues Motor Deficits and Neurodegeneration in a Mouse Model of Parkinson's Disease.

Abstract
Glial cell-derived neurotrophic factor (GDNF) has a potent action in promoting the survival of dopamine (DA) neurons. Several studies indicate that increasing GDNF levels may be beneficial for the treatment of Parkinson's disease (PD) by reducing neurodegeneration of DA neurons. Despite a plethora of preclinical studies showing GDNF efficacy in PD animal models, its application in humans remains questionable for its poor efficacy and side effects due to its uncontrolled, ectopic expression. Here we took advantage of SINEUPs, a new class of antisense long non-coding RNA, that promote translation of partially overlapping sense protein-coding mRNAs with no effects on their mRNA levels. By synthesizing a SINEUP targeting Gdnf mRNA, we were able to increase endogenous GDNF protein levels by about 2-fold. Adeno-associated virus (AAV)9-mediated delivery in the striatum of wild-type (WT) mice led to an increase of endogenous GDNF protein for at least 6 months and the potentiation of the DA system's functions while showing no side effects. Furthermore, SINEUP-GDNF was able to ameliorate motor deficits and neurodegeneration of DA neurons in a PD neurochemical mouse model. Our data indicate that SINEUP-GDNF could represent a new strategy to increase endogenous GDNF protein levels in a more physiological manner for therapeutic treatments of PD.
AuthorsStefano Espinoza, Margherita Scarpato, Devid Damiani, Francesca Managò, Maddalena Mereu, Andrea Contestabile, Omar Peruzzo, Piero Carninci, Claudio Santoro, Francesco Papaleo, Federico Mingozzi, Giuseppe Ronzitti, Silvia Zucchelli, Stefano Gustincich
JournalMolecular therapy : the journal of the American Society of Gene Therapy (Mol Ther) Vol. 28 Issue 2 Pg. 642-652 (02 05 2020) ISSN: 1525-0024 [Electronic] United States
PMID31495777 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Glial Cell Line-Derived Neurotrophic Factor
  • RNA, Untranslated
Topics
  • Animals
  • Corpus Striatum (metabolism, pathology)
  • Dependovirus (genetics)
  • Disease Models, Animal
  • Dopaminergic Neurons (metabolism)
  • Gene Expression Regulation
  • Gene Transfer Techniques
  • Genetic Vectors (genetics)
  • Glial Cell Line-Derived Neurotrophic Factor (genetics, metabolism)
  • Humans
  • Immunohistochemistry
  • Mice
  • Motor Neurons (metabolism, pathology)
  • Neurodegenerative Diseases (genetics, metabolism, pathology)
  • Parkinson Disease (genetics, metabolism, pathology)
  • Phenotype
  • RNA Interference
  • RNA, Untranslated (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: